Daxor Corporation is the global leader in blood volume measurement technology focused on blood testing innovation. Blood volume analysis (BVA) is the first diagnostic blood test cleared by the FDA to provide safe, 98% accurate, objective quantification of blood volume status and composition compared to patient-specific norms to help guide individualized volume management in a wide variety of medical conditions.
Over 65,000+ tests have been performed to evaluate blood volume and is being used daily in major centers across the U.S. A prospective randomized control trial showed that BVA-guided treatment modified fluid and red blood cell interventions in 44% of cases, reducing mortality by 66% in surgical ICUs while shortening hospital stays and time on ventilators.
Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for all.